Lv21
170 积分 2024-07-17 加入
Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients
2小时前
求助中
Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes
5天前
已完结
Next generation sequencing for detection of EGFR alterations in NSCLC: is more better?
2个月前
已完结
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
2个月前
已完结
Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
2个月前
已完结
EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study
3个月前
已完结
Sunvozertinib for the treatment of NSCLC with EGFR Exon20 insertion mutations: The first pivotal study results
3个月前
已完结
Phase (Ph) 1/2a study of CLN-081 in patients (pts) with NSCLC with EGFR exon 20 insertion mutations (Ins20)
3个月前
已完结
Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models
3个月前
已完结
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
3个月前
已完结
皖公网安备34019202002308
